|

JD123 injection Clinical Trials

1 actively recruiting trial

Pipeline

Early 1: 1

Top Sponsors

  • Peking University People's Hospital1

Indications

  • Acute Myeloid Leukemia, in Relapse1
  • Acute Myeloid Leukemia Refractory1
  • Cancer1

Other1 trial

Off-the-shelf CD123 CAR-NK for R/R AML
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.